ASCO GU Keynote: Future Clinical Trials in Renal Cell Cancer

Daniel J. George, MD, of Duke Cancer Institute, gives an overview of what is on the horizon in renal cell cancer (RCC) research. Topics discussed include emerging clinical trials, how to move forward with predictive biomarkers, clinical outcomes for RCC trials, and unmet needs in advanced RCC that Dr. George describes as being “imminently attainable.”03/01/2015
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news